Results 41 to 50 of about 94,588 (272)
American Journal of Ophthalmology Case Reports, 2018 Purpose: To evaluate the effect of salvage therapy with bevacizumab after laser photocoagulation for infants with recurrence of zone I aggressive-posterior retinopathy of prematurity (AP-ROP). Methods: This was a retrospective case series documenting the
Yoko Fukushima +4 more
doaj +1 more source
Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods
International Journal of Retina and Vitreous, 2020 Background To compare and assess the efficacy of three surgical methods for the treatment of acute submacular hemorrhage (ASH): pneumatic displacement with C2F6, in combination with intravitreal injection of bevacizumab and rtPA, pars plana vitrectomy ...
Carsten Grohmann +6 more
doaj +1 more source
Intravitreal Bevacizumab in Retinopathy of Prematurity
Asia-Pacific Journal of Ophthalmology, 2014 This article is aimed to review and summarize the indications, outcomes and safety profiles regarding the use of intravitreal bevacizumab in patients with retinopathy of prematurity (ROP) as reported in previous studies with no intention to compare the efficacy between intravitreal bevacizumab and laser photocoagulation.Literature search was conducted ...
Dini, Hapsari, Rita S, Sitorus
openaire +2 more sources
Case Reports in Ophthalmology, 2014 We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge,
Aditya Kelkar +6 more
doaj +1 more source
Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario
Indian Journal of Ophthalmology, 2017 Purpose: The purpose of this study was to evaluate the safety profile of intravitreal bevacizumab (Avastin) as an off-label pharmacotherapeutic agent for various ocular conditions.
P. Jain +3 more
semanticscholar +1 more source
Erectile dysfunction following intravitreal bevacizumab
Middle East African Journal of Ophthalmology, 2010 Despite initial concerns regarding systemic complications, the use of intravitreal antivascular endothelial growth factor (anti-VEGF) agents for ocular disease is rapidly expanding worldwide, in terms of both the number of patients injected and its indications.
Yohendran, Jayshan, Chauhan, Devinder
openaire +3 more sources
Reflux after Intravitreal Injection of Bevacizumab [PDF]
Ophthalmology, 2008 Contains fulltext : 71203.pdf (Publisher’s version ) (Open Access)
Boon, C.J.F. +4 more
openaire +2 more sources
Ophthalmology (Rochester, Minn.), 2016 PURPOSE To determine (1) incidence, (2) risk factors, (3) risk period, and (4) characteristics of recurrent retinopathy of prematurity (ROP) treated by intravitreal bevacizumab (IVB) monotherapy. DESIGN Retrospective case series.
H. Mintz‐Hittner +2 more
semanticscholar +1 more source
Response of diabetic papillopathy to intravitreal bevacizumab
Middle East African Journal of Ophthalmology, 2011 Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab (Avastin ...
Al-Dhibi, Hassan, Khan, Arif O.
openaire +3 more sources
Oman Journal of Ophthalmology, 2018 This report describes a lamellar macular hole formation subsequent to intravitreal bevacizumab injection for the treatment of choroidal neovascularization (CNV) by age-related macular degeneration.
Hamidreza Torabi +2 more
doaj +1 more source